Latest Breaking News On - Anlong bio - Page 1 : comparemela.com

Chicago-based VectorBuilder, a gene therapy delivery CDMO, raised $57 million in a Series C round from China investors.

United statesAnlong bioAscletis pharmaHealth fundMaxinovel pharmaceuticalsYuexiu industrial fundChina merchants direct investmentsUnifortune groupTonghua investment groupShenzhen salubris pharmaceuticalsGuangzhou development district investment groupLegend capitalSuikai investmentGuangdian capitalZhonghe oupu medicalFocus fund